Neurology symposium report

被引:0
作者
Taylor, K. [1 ]
机构
[1] Southern Gen Hosp, Inst Neurol Sci, Neurol, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland
关键词
Multiple sclerosis; neurology; NICE; Parkinson's disease; subarachnoid haemorrhage; symposium;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Royal College of Physicians of Edinburgh held its latest Neurology Symposium on 9 November 2006. The topics, summarised in this report, included useful clinical approaches to some common neurological problems (blackouts, dizziness, headache, and functional symptoms), original basic and clinical research on subarachnoid haemorrhage, a discussion of exciting new advances made in multiple sclerosis over the last 10 years, and current thinking on the management of Parkinson's disease. Finally, a debate on the controversial issue of the role of NICE in neurology concluded that NICE had not enhanced the care of neurological patients in the UK. However, there was a general consensus that there is an important role for an organisation to appraise neurological healthcare interventions.
引用
收藏
页码:352 / 356
页数:5
相关论文
共 31 条
[1]   Axonal protection achieved in a model of multiple sclerosis using lamotrigine [J].
Bechtold, David A. ;
Miller, Sandra J. ;
Dawson, Angela C. ;
Sun, Yue ;
Kapoor, Raju ;
Berry, David ;
Smith, Kenneth J. .
JOURNAL OF NEUROLOGY, 2006, 253 (12) :1542-1551
[2]   Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE [J].
Black, Joel A. ;
Liu, Shujun ;
Hains, Bryan C. ;
Saab, Carl Y. ;
Waxman, Stephen G. .
BRAIN, 2006, 129 :3196-3208
[3]   Vestibular reflexes and positional manoeuvres [J].
Bronstein, AM .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (03) :289-293
[4]   The window of therapeutic opportunity in multiple sclerosis [J].
Coles, AJ ;
Cox, A ;
Le Page, E ;
Jones, J ;
Trip, SA ;
Deans, J ;
Seaman, S ;
Miller, DH ;
Hale, G ;
Waldmann, H ;
Compston, DA .
JOURNAL OF NEUROLOGY, 2006, 253 (01) :98-108
[5]   Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis [J].
Coman, I. ;
Aigrot, M. S. ;
Seilhean, D. ;
Reynolds, R. ;
Girault, J. A. ;
Zalc, B. ;
Lubetzki, C. .
BRAIN, 2006, 129 :3186-3195
[6]  
Craig JJ, 1997, BRIT J HOSP MED, V57, P202
[7]   Evidence-based understanding of medication-overuse headache: Clinical implications [J].
Dodick, David ;
Freitag, Frederick .
HEADACHE, 2006, 46 :S202-S211
[8]   Therapeutic considerations for disease progression in multiple sclerosis -: Evidence, experience, and future expectations [J].
Frohman, EM ;
Stüve, O ;
Havrdova, E ;
Corboy, J ;
Achiron, A ;
Zivadinov, R ;
Sorensen, PS ;
Phillips, JT ;
Weinshenker, B ;
Hawker, K ;
Hartung, HP ;
Steinman, L ;
Zamvil, S ;
Cree, BAC ;
Hauser, S ;
Weiner, H ;
Racke, MK ;
Filippi, M .
ARCHIVES OF NEUROLOGY, 2005, 62 (10) :1519-1530
[9]   Characterizing the mechanisms of progression in multiple sclerosis - Evidence and new hypotheses for future directions [J].
Frohman, EM ;
Filippi, M ;
Stuve, O ;
Waxman, SG ;
Corboy, J ;
Phillips, JT ;
Lucchinetti, C ;
Wilken, J ;
Karandikar, N ;
Hemmer, B ;
Monson, N ;
De Keyser, J ;
Hartung, H ;
Steinman, L ;
Oksenberg, JR ;
Cree, BAC ;
Hauser, S ;
Racke, MK .
ARCHIVES OF NEUROLOGY, 2005, 62 (09) :1345-1356
[10]  
Gregory R, 2002, J NEUROL NEUROSUR PS, V72, pI32